Skip to content

Henry Schein HSIC Add - Incremental shares under stock-based compensation plans (in shares)

Add - Incremental shares under stock-based compensation plans (in shares) at other companies

Medline, Inc.
 logo
Medline, Inc. MDLN
Solventum logo
SolventumSOLV
Brown & Brown logo
Brown & BrownBRO
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST

Other financials

Income statement

See full
Revenue$3.4B+6.3%
Gross profit$1.1B+7.0%
Operating income$182.0M+4.0%
Net income$107.0M-2.7%
EPS (diluted)$0.92+4.5%

Balance sheet

See full
Cash & equivalents$138.0M+8.7%
Total debt$3.7B+17.2%
Total equity$3.3B-1.3%
Total assets$11.3B+7.9%

Cash flow

See full
Operating cash flow-$97.0M-362%
CapEx$25.0M-19.4%
Free cash flow-$122.0M-2,133%

Valuation

See full
Market cap$9.1B-0.6%
Enterprise value$12.69B+4.2%
P/E23.1×+0.5×
P/S0.7×0.0×

Profitability

See full
Gross margin31.2%-0.4pp
Operating margin4.9%-0.2pp
Net margin3%-0.3pp
FCF margin3.3%-1.0pp

Returns & leverage

See full
Return on equity12%+0.2pp
Debt / equity1.1×+0.2×
Current ratio1.4×0.0×

Where this comes from

Reported directly by Henry Schein in its filing.

Tagged under the XBRL concept us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements.

The official record: Henry Schein’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Henry Schein's add - incremental shares under stock-based compensation plans (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Henry Schein's add - incremental shares under stock-based compensation plans (in shares)?
Henry Schein (HSIC) reported add - incremental shares under stock-based compensation plans (in shares) of $1.12M in Q1 2026.
How has Henry Schein's add - incremental shares under stock-based compensation plans (in shares) changed year-over-year?
Henry Schein's add - incremental shares under stock-based compensation plans (in shares) increased by 4.6% year-over-year, from $1.07M to $1.12M.
What is the long-term trend for Henry Schein's add - incremental shares under stock-based compensation plans (in shares)?
Over 2 years (2023 to 2025), Henry Schein's add - incremental shares under stock-based compensation plans (in shares) has grown at a -25.9% compound annual growth rate (CAGR), from $4.82M to $2.65M.
What does add - incremental shares under stock-based compensation plans (in shares) mean?
The number of potential new shares from employee stock compensation plans.
How do you interpret add - incremental shares under stock-based compensation plans (in shares)?
An increase indicates higher potential dilution for existing shareholders, which may impact future earnings per share.
How does add - incremental shares under stock-based compensation plans (in shares) compare across companies?
Standard disclosure for all public companies with equity-based compensation programs.